SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-16-012164
Filing Date
2016-04-13
Accepted
2016-04-13 16:30:42
Documents
6
Period of Report
2016-05-26
Effectiveness Date
2016-04-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2228196zdef14a.htm DEF 14A 349325
2 G851446.JPG g851446.jpg GRAPHIC 19652
3 G248959.JPG g248959.jpg GRAPHIC 4894
4 G552984.JPG g552984.jpg GRAPHIC 4602
5 G21282BG01I001.GIF g21282bg01i001.gif GRAPHIC 154223
6 G21282BG01I002.GIF g21282bg01i002.gif GRAPHIC 38691
  Complete submission text file 0001047469-16-012164.txt   656555
Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034
Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000
Vitae Pharmaceuticals, Inc (Filer) CIK: 0001157602 (see all company filings)

IRS No.: 043567753 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36617 | Film No.: 161569542
SIC: 2834 Pharmaceutical Preparations